I agree that this site is using cookies. You can find further informations here.
X
Heinzle, Christine
28  results:
OpenAccess-fulltext X
Search for persons X
?
1

Coronary Event Risk Test (CERT) as a Risk Predictor for the..:

Leiherer, Andreas ; Muendlein, Axel ; Saely, Christoph H...
6151.  , 2023
Link: https://trepo.tuni.fi/ha..
 
?
2

Circulating syndecan-1 and glypican-4 predict 12-month surv..:

Muendlein, Axel ; Severgnini, Luciano ; Decker, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638102/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Molecules / Volatilomic signatures of AGS and SNU-1 gastric..:

Ślefarska-Wolak, Daria ; Heinzle, Christine ; Leiherer, Andreas...
vignette : https://diglib.uibk.ac.at/titlepage/urn/urn:nbn:at:at-ubi:3-32517/128.  , 2022
Link: https://doi.org/10.3390/..
 
?
4

Data on the association of serum glypican-4 with future maj..:

Muendlein, Axel ; Brandtner, Eva Maria ; Leiherer, Andreas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046629/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Evaluation of the association of serum glypican-4 with prev..:

Muendlein, Axel ; Brandtner, Eva Maria ; Leiherer, Andreas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206029/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

The Volatilomic Footprints of Human HGC-27 and CLS-145 Gast..:

Leiherer, Andreas ; Ślefarska, Daria ; Leja, Marcis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874186/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 ..:

Erdem, Zeynep N ; Schwarz, Stefanie ; Drev, Daniel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367848/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
8

Translational Oncology / Irinotecan Upregulates Fibroblast ..:

Marian, Brigitte ; Erdem, Zeynep N ; Schwarz, Stefanie...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-15055/128.  , 2017
Link: https://resolver.obvsg.a..
 
?
9

Is Fibroblast Growth Factor Receptor 4 a Suitable Target of..:

Heinzle, Christine ; Erdem, Zeynep ; Paur, Jakob...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453246/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
10

Fibroblast growth factor receptor 4: a putative key driver ..:

Gauglhofer, Christine ; Paur, Jakob ; Schrottmaier, Waltraud C...
http://orbilu.uni.lu/handle/10993/26734.  , 2014
Link: http://orbilu.uni.lu/han..
 
?
11

Fibroblast Growth Factor Receptors as Therapeutic Targets i..:

Metzner, Thomas ; Bedeir, Alexandra ; Held, Gerlinde...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383623.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
12

Data on the impact of peripheral artery disease and of type..:

Saely, Christoph H ; Schindewolf, Marc ; Zanolin, Daniela...
https://boris.unibe.ch/123379/.  , 2018
Link: https://boris.unibe.ch/1..
 
?
13

Coronary Event Risk Test (CERT) as a Risk Predictor for the..:

Andreas Leiherer ; Axel Muendlein ; Christoph H. Saely...
https://www.mdpi.com/2077-0383/12/19/6151.  , 2023
Link: https://doi.org/10.3390/..
 
?
14

Circulating syndecan-1 and glypican-4 predict 12-month surv..:

Axel Muendlein ; Luciano Severgnini ; Thomas Decker...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1045995/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
15

Evaluation of the association of serum glypican-4 with prev..:

Axel Muendlein ; Eva Maria Brandtner ; Andreas Leiherer...
https://doi.org/10.1038/s41598-022-14306-7.  , 2022
Link: https://doi.org/10.1038/..
 
1-15